Recent #Overvaluation news in the semiconductor industry

3 months ago
1. The author argues Celestica is significantly overvalued due to its low gross margins (10%) and inability to invest in building competitive advantages; 2. Despite improved operating margins and upbeat FY2025 guidance, the stock's recent rally is deemed unsustainable given weak R&D spending and lack of innovation; 3. The bearish thesis emphasizes that Celestica’s fundamentals do not justify its current valuation, despite short-term price fluctuations.
Market SentimentOvervaluationfinancial performance
3 months ago
1. The authors closed their short position in Palantir at a loss after the stock surged 40% since April; 2. They acknowledge being wrong on timing but maintain the company is fundamentally overvalued; 3. Palantir is rated a SELL due to minimal margin of safety and irrational market behavior.
Overvaluation
9 months ago
1. Palantir Technologies Inc. is trading at an extremely high valuation, with a forward sales multiple of 57x and a market cap over $150 billion despite modest revenue growth. 2. The company's fundamentals are improving, but the current valuation is unsustainable, posing significant risk if growth stalls or estimates are missed. 3. Multiple expansion has driven recent gains, but comparisons to Snowflake and Zoom suggest potential for severe valuation contraction. Investors face the risk of minimal returns or substantial losses over the coming years.
Overvaluationmarket analysis
11 months ago
1. Palantir is significantly overvalued with a forward EV-to-sales ratio of 34 and a forward price-to-cash-flow ratio of 111.3, indicating a high-risk investment. 2. Despite expected strong Q3 results, the current valuation is unsustainable. 3. The company's commercial revenue growth driven by its AI Platform and boot camps is promising, but its reliance on wartime economics poses long-term risks. 4. Given the speculative nature of its current valuation, consider selling PLTR stock now as a significant correction is likely.
Investment AnalysisOvervaluationstock market